Inventor
BIFULCO JR NEIL
US15 patents
⚠️ This page may combine multiple inventors who share the name “BIFULCO JR NEIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BLUEPRINT MEDICINES CORP
11 patentsUS9340514B2May 17, 2016
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP43 citations97
US10000490B2Jun 19, 2018
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP30 citations94
US9695165B2Jul 4, 2017
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP40 citations94
US10017512B2Jul 10, 2018
Compounds and compositions useful for treating disorders related to NTRK
BLUEPRINT MEDICINES CORP29 citations93
US10221154B2Mar 5, 2019
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP11 citations84
US10875837B2Dec 29, 2020
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP1 citations73
US11046697B2Jun 29, 2021
Compounds and compositions useful for treating disorders related to NTRK
BLUEPRINT MEDICINES CORP5 citations72
US11970498B2Apr 30, 2024
CDK2 inhibitors
BLUEPRINT MEDICINES CORP1 citations71
US10370379B2Aug 6, 2019
Compounds and compositions useful for treating disorders related to NTRK
BLUEPRINT MEDICINES CORP1 citations62
US12545684B2Feb 10, 2026
CDK2 inhibitors
BLUEPRINT MEDICINES CORP0 citations61
US11932648B2Mar 19, 2024
CDK2 inhibitors
BLUEPRINT MEDICINES CORP1 citations61
BIFULCO JR NEIL
3 patentsUS9434700B2Sep 6, 2016
Inhibitors of the fibroblast growth factor receptor
BIFULCO JR NEIL45 citations97
US9126951B2Sep 8, 2015
Inhibitors of the fibroblast growth factor receptor
BIFULCO JR NEIL47 citations97
US8802697B2Aug 12, 2014
Inhibitors of the fibroblast growth factor receptor
BIFULCO JR NEIL91 citations97